SCHEMBL24399498

SCHEMBL24399498

CCCN(C)CC(C)C(C)C

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.36
GGPS1 O95749 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18635881 0.82 PIK3CD (0.36) PIK3CD
SCHEMBL23733349 0.81 PIK3CD (0.34) PIK3CDGGPS1
SCHEMBL2973925 0.80
SCHEMBL12059200 0.80 PIK3CD (0.32) PIK3CD
SCHEMBL21922963 0.79 PIK3CD (0.33) PIK3CDGGPS1
SCHEMBL21367225 0.79 SIGMAR1 (0.31)
SCHEMBL13520199 0.79 GGPS1 (0.32) PIK3CDGGPS1
SCHEMBL18827276 0.78 PIK3CD (0.41) PIK3CD
SCHEMBL19227415 0.77 PIK3CD (0.32) PIK3CD
SCHEMBL27447413 0.77 PIK3CD (0.32) PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023247590-A1 TRIAZOLOPYRIDINE AND BENZOISOXAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2023-12-28 WO disclosed
WO-2023197129-A1 ONCOLYTIC PEPTIDE AND USE THEREOF RISE BIOPHARMACEUTICALS INC. (CN) 2023-10-19 WO disclosed
US-20220211750-A1 COMPOSITIONS AND METHODS USING A COMBINATION OF CALCIUM AND AT LEAST ONE OF OLEUROPEIN OR METABOLITE THEREOF NESTLE SA (CH) 2022-07-07 US disclosed
WO-2022094271-A1 METHODS FOR TREATING CANCER SCORPION THERAPEUTICS, INC. (US) 2022-05-05 WO disclosed